Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 16, Issue 3, 2014, Pages

  Bengtsson, Anders A ^a   Pettersson, Åsa ^b   Wichert, Stina ^a   Gullstrand, Birgitta ^c   Hansson, Markus ^a   Hellmark, Thomas ^b   Johansson, Åsa C M ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Lund University   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD11B ANTIGEN; CD16 ANTIGEN; CHLOROQUINE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C5A RECEPTOR; CYCLOSPORIN A; HYDROXYCHLOROQUINE; L SELECTIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHORBOL 13 ACETATE 12 MYRISTATE; PREDNISONE; REACTIVE OXYGEN METABOLITE; RITUXIMAB; FC RECEPTOR; MEMBRANE METALLOENDOPEPTIDASE;

ADULT; AGED; ARTICLE; BLOOD; BONE MARROW; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESCHERICHIA COLI; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VIVO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION AND CHARACTERISTICS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; POLYMORPHONUCLEAR LEUKOCYTE RELEASE; PROTEIN EXPRESSION; REDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD11B; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; L-SELECTIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEPRILYSIN; NEUTROPHILS; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, IGG; TETRADECANOYLPHORBOL ACETATE; YOUNG ADULT;

EID: 84903134145     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4575     Document Type: Article

References (36)

1. Bengtsson A, Nezlin R, Shoenfeld Y, Sturfelt G. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. J Autoimmun 1999, 13:111-119. 10.1006/jaut.1999.0300, 10441175.
2. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1241-1250. 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H, 9663482.
3. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 2005, 4:189-194. 10.1016/j.autrev.2004.10.007, 15893710.
4. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA 2010, 107:9813-9818. 10.1073/pnas.0909927107, 2906830, 20439745.
5. Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, Bengtsson AA, Blom AM. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 2012, 188:3522-3531. 10.4049/jimmunol.1102404, 22345666.
6. Kaneko T, Stearns-Kurosawa DJ, Taylor F, Twigg M, Osaki K, Kinasewitz GT, Peer G, Kurosawa S. Reduced neutrophil CD10 expression in nonhuman primates and humans after in vivo challenge with E. coli or lipopolysaccharide. Shock 2003, 20:130-137. 10.1097/01.shk.0000068326.68761.34, 12865656.
7. Orr Y, Taylor JM, Bannon PG, Geczy C, Kritharides L. Circulating CD10-/CD16low neutrophils provide a quantitative index of active bone marrow neutrophil release. Br J Haematol 2005, 131:508-519. 10.1111/j.1365-2141.2005.05794.x, 16281943.
8. Jonsson F, Mancardi DA, Albanesi M, Bruhns P. Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions. J Leukoc Biol 2013, 94:643-656. 10.1189/jlb.1212623, 23532517.
9. Rosetti F, Tsuboi N, Chen K, Nishi H, Ernandez T, Sethi S, Croce K, Stavrakis G, Alcocer-Varela J, Gomez-Martin D, van Rooijen N, Kyttaris VC, Lichtman AH, Tsokos GC, Mayadas TN. Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency. J Immunol 2012, 189:3714-3723. 10.4049/jimmunol.1201594, 3462585, 22933624.
10. Furebring M, Hakansson L, Venge P, Sjolin J. Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes. Scand J Immunol 2004, 60:494-499. 10.1111/j.0300-9475.2004.01499.x, 15541042.
11. Smith CW. Leukocyte-endothelial cell interactions. Semin Hematol 1993, 30:45-53. discussion 54-45.
12. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313. 10.1152/physrev.00044.2005, 17237347.
13. Hansson M, Hermodsson S, Brune M, Mellqvist UH, Naredi P, Betten A, Gehlsen KR, Hellstrand K. Histamine protects T cells and natural killer cells against oxidative stress. J Interferon Cytokine Res 1999, 19:1135-1144. 10.1089/107999099313073, 10547153.
14. Hansson M, Romero A, Thoren F, Hermodsson S, Hellstrand K. Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytes. J Leukoc Biol 2004, 76:1207-1213. 10.1189/jlb.0204113, 15361542.
15. Holmdahl R, Sareila O, Pizzolla A, Winter S, Hagert C, Jaakkola N, Kelkka T, Olsson LM, Wing K, Backdahl L. Hydrogen peroxide as an immunological transmitter regulating autoreactive T cells. Antioxid Redox Signal 2013, 18:1463-1474. 10.1089/ars.2012.4734, 22900704.
16. Mellqvist UH, Hansson M, Brune M, Dahlgren C, Hermodsson S, Hellstrand K. Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood 2000, 96:1961-1968.
17. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, Ortmann W, Kosoy R, Ferreira RC, Nordmark G, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jönsen A, Bengtsson AA, Rantapää-Dahlqvist S, Baechler EC, Brown EE, Alarcón GS, Edberg JC, Ramsey-Goldman R, McGwin G, Reveille JD, Vilá LM, Kimberly RP, Manzi S, Petri MA, Lee A, Gregersen PK, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41:1228-1233. 10.1038/ng.468, 2925843, 19838195.
18. Johnston RB. Clinical aspects of chronic granulomatus disease. Curr Opin Hematol 2001, 8:17-22. 10.1097/00062752-200101000-00004, 11138621.
19. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000, 79:170-200. 10.1097/00005792-200005000-00004, 10844936.
20. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
21. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002, 29:288-291.
22. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A. The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39:363-369. 10.1002/art.1780390303, 8607884.
23. Perazzio SF, Salomao R, Silva NP, Andrade LE. Increased neutrophil oxidative burst metabolism in systemic lupus erythematosus. Lupus 2012, 21:1543-1551. 10.1177/0961203312461060, 23012249.
24. Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T. Neutrophil activation in Behcet's disease. Clin Exp Rheumatol 2001, 19:S19-S24.
25. Mossberg N, Andersen O, Nilsson S, Dahlgren C, Hellstrand K, Lindh M, Svedhem A, Bergstrom T, Movitz C. Oxygen radical production and severity of the Guillain-Barre syndrome. J Neuroimmunol 2007, 192:186-191. 10.1016/j.jneuroim.2007.09.020, 17945354.
26. Mossberg N, Movitz C, Hellstrand K, Bergstrom T, Nilsson S, Andersen O. Oxygen radical production in leukocytes and disease severity in multiple sclerosis. J Neuroimmunol 2009, 213:131-134. 10.1016/j.jneuroim.2009.05.013, 19589606.
27. El-Benna J, Dang PM, Gougerot-Pocidalo MA. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol 2008, 30:279-289. 10.1007/s00281-008-0118-3, 18536919.
28. Alves CMM-MC, Carvalho IF, Lucisano Valim YM. Application of the chemiluminescence systems to evaluate the role of Fcgamma and complement receptors in stimulating the oxidative burst in neutrophils. Talanta 2003, 60:601-608. 10.1016/S0039-9140(03)00188-7, 18969082.
29. Shah D, Aggarwal A, Bhatnagar A, Kiran R, Wanchu A. Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus. Free Radic Res 2011, 45:559-567. 10.3109/10715762.2011.555765, 21284579.
30. Fukushima K, Ando M, Ito K, Suga M, Araki S. Stimulus- and cumulative dose-dependent inhibition of O2- production by polymorphonuclear leukocytes of patients receiving corticosteroids. J Clin Lab Immunol 1990, 33:117-123.
31. Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med 1991, 80:605-612.
32. Hepburn AL, Narat S, Mason JC. The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology (Oxford) 2010, 49:2243-2254. 10.1093/rheumatology/keq269, 20823093.
33. Papadaki HA, Boumpas DT, Gibson FM, Jayne DR, Axford JS, Gordon-Smith EC, Marsh JC, Eliopoulos GD. Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 2001, 115:167-174. 10.1046/j.1365-2141.2001.03076.x, 11722430.
34. Elghetany MT. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis 2002, 28:260-274. 10.1006/bcmd.2002.0513, 12064921.
35. Furebring M, Hakansson LD, Venge P, Nilsson B, Sjolin J. Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis. Crit Care 2002, 6:363-370. 10.1186/cc1524, 125318, 12225614.
36. Furebring M, Hakansson L, Venge P, Sjolin J. C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes. Scand J Immunol 2006, 63:208-216. 10.1111/j.1365-3083.2006.01724.x, 16499574.